Artiva Biotherapeutics (ARTV) Asset Utilization Ratio (2024)
Artiva Biotherapeutics' (ARTV) quarterly Asset Utilization Ratio came in at 0.0 in Q4 2024, down 93.31% on a QoQ basis from 0.02 in Q3 2024.
Artiva Biotherapeutics (ARTV) Asset Utilization Ratio (2024) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 1 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q4 2024.
- On a quarterly basis, Asset Utilization Ratio changed N/A year-over-year to 0.0 in Q4 2024; TTM through Dec 2024 was 0.0, a N/A change from a year earlier, with the FY2024 full-year figure at 0.0, changed N/A from the prior year.
- Asset Utilization Ratio for Q4 2024 stood at 0.0, down from 0.02 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for ARTV reached as high as 0.02 in Q3 2024 and fell as low as 0.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Artiva Biotherapeutics | 249.99 Mn | 249.99 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.02 |